Jun-Min Zhou

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer

Richard D. Kim, Vincent Chung, Olatunji B. Alese et al. · JAMA Oncology · 2020 · 435 citations · Full text

Synthesis and Evaluation of Quindoline Derivatives as G-Quadruplex Inducing and Stabilizing Ligands and Potential Inhibitors of Telomerase

Jin-Lin Zhou, Yu‐Jing Lu, Tian-Miao Ou et al. · Journal of Medicinal Chemistry · 2005 · 171 citations

Cell-surface marker discovery for lung cancer

Allison S. Cohen, Farah Khalil, Eric A. Welsh et al. · Oncotarget · 2017 · 84 citations · Full text

Silencing of LMP1 Induces Cell Cycle Arrest and Enhances Chemosensitivity Through Inhibition of AKT Signaling Pathway in EBV-Positive Nasopharyngeal Carcinoma Cells

Yu-Ping Mei, Jun-Min Zhou, Yi Wang et al. · Cell Cycle · 2007 · 72 citations · Full text

Blockade of Vascular Endothelial Growth Factor Receptor Signal Pathway and Antitumor Activity of ON-III (2′,4′-Dihydroxy-6′-methoxy-3′,5′-dimethylchalcone), a Component from Chinese Herbal Medicine

Xiao‐Feng Zhu, Bin-Fen Xie, Jun-Min Zhou et al. · Molecular Pharmacology · 2005 · 64 citations